Journals / Records of Natural Products / 2022 / Cilt: 16 - Sayı: 2

In vitro ACE2 and 5-LOX Inhibition of Rosmarinus officinalis L. Essential Oil and its Major Component 1,8-Cineole

Pages
194–199
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further in vivo studies are needed to confirm the efficacy of essential oils and their constituents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this present study, Rosmarinus officinalis L. essential oil, and its major component 1,8-cineole was evaluated in vitro for angiotensin converting enzyme 2 (ACE2), as well as for 5-lipoxygenase (5-LOX) enzyme inhibitory activity.
📊
Key Findings & Data:The essential oil composition was confirmed both by GC-FID and GC/MS, where 1,8-cineole (62.7%), α-pinene (12.6 %), and camphor (8.3 %) were identified as the main constituents.
💡
Conclusion & Impact:Further in vivo studies are needed to confirm the efficacy of essential oils and their constituents.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this present study, Rosmarinus officinalis L. essential oil, and its major component 1,8-cineole was evaluated in vitro for angiotensin converting enzyme 2 (ACE2), as well as for 5-lipoxygenase (5-LOX) enzyme inhibitory activity. The essential oil composition was confirmed both by GC-FID and GC/MS, where 1,8-cineole (62.7%), α-pinene (12.6 %), and camphor (8.3 %) were identified as the main constituents. Activity studies were performed at concentrations of 20 µg/mL for essential oil, and 5 µg/mL for the major compound 1,8-cineole, which were compared experimentally with standards. The essential oil was evaluated using a fluorometric multiplate based enzyme inhibition kit, where the ACE2 inhibition of Rosmarinus aetheroleum was 20%, while the 5-LOX inhibition was observed as 81.1%, respectively. In addition, the major constituent 1,8-cineole also showed remarkable ACE2 inhibition with 89.2%, and 5-LOX inhibition with 37.2%, respectively. As a result, the cineole chemotype rosemary essential oil, and its major constituent 1,8-cineol may have antiviral potential applications against coronaviruses due to ACE2 enzyme inhibition with anti-inflammatory effects. Further in vivo studies are needed to confirm the efficacy of essential oils and their constituents.

🔖

Cite This Article

KARADAĞ, A. E., DEMİRCİ, B., DEMİRCİ, F., BİLTEKİN, S. N. (2022). In vitro ACE2 and 5-LOX Inhibition of Rosmarinus officinalis L. Essential Oil and its Major Component 1,8-Cineole. Records of Natural Products, Cilt: 16 - Sayı: 2, 194–199. https://ajindex.com/articles/588768

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. R.S. Borges, B.L.S. Ortiz, A.C.M. Pereira, H. Keita and J.C.T. Carvalho (2019). Rosmarinus officinalis essential oil: A review of its phytochemistry, anti-inflammatory activity, and mechanisms of action involved. J. Ethnopharmacol. 229, 29-45
  2. A. Kompelly, S. Kompelly, B. Vasudha and B. Narender (2019). Rosmarinus officinalis L.: An update review of its phytochemistry and biological activity, J. Drug Deliv. Ther. 9, 323-330
  3. S. Selmi, K. Rtibi, D. Grami, H. Sebai and L. Marzouki (2017). Rosemary (Rosmarinus officinalis) essential oil components exhibit anti-hyperglycemic, anti-hyperlipidemic and antioxidant effects in experimental diabetes, Pathophysiology 24, 297–303
  4. M. Khoobdel, S.M. Ahsaei, and M. Farzaneh (2017). Insecticidal activity of polycaprolactone nanocapsules loaded with Rosmarinus officinalis essential oil in Tribolium castaneum (Herbst), Entomol. Res. 47, 175– 184
  5. A.I. Hussain, F. Anwar, S.A.S. Chatha, A. Jabbar, S. Mahboob and P.S. Nigam (2010). Rosmarinus officinalis essential oil: Antiproliferative, antioxidant and antibacterial activities, Brazilian J. Microbiol. 41, 1070–1078
  6. L. Gachkar, D. Yadegari, M.B. Rezaei, M. Taghizadeh, S.A. Astaneh and I. Rasooli (2007). Chemical and biological characteristics of Cuminum cyminum and Rosmarinus officinalis essential oils, Food Chem. 102, 898–904
  7. O.Y. Celiktas, E.E.H. Kocabas, E. Bedir, F.V. Sukan, T. Ozek and K.H.C. Baser (2007). Antimicrobial activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on location and seasonal variations, Food Chem. 100, 553–559
  8. P. Satyal, T. Jones, E. Lopez, R. McFeeters, N. Ali, I. Mansi, A. Al-kaf, W. Setzer, P. Satyal, T.H. Jones, E.M. Lopez, R.L. McFeeters, N.A.A. Ali, I. Mansi, A.G. Al-kaf and W.N. Setzer (2017). Chemotypic characterization and biological activity of Rosmarinus officinalis, Foods. 6, 20
  9. M. Kačániová, N. Vukovič, E. Horská, I. šalamon, A. Bobková, L. Hleba, M. Mellen, A. Vatľák, J. Petrová and M. Bobko (2014). Antibacterial activity against Clostridium genus and antiradical activity of the essential oils from different origin, J. Environ. Sci. Heal. Part B. 49, 505–512
  10. I. Takaki, L.E. Bersani-Amado, A. Vendruscolo, S.M. Sartoretto, S.P. Diniz, C.A. Bersani-Amado and R.K.N. Cuman (2008). Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models, J. Med. Food. 11,741–746
  11. M. Liu, T. Wang, Y. Zhou, Y. Zha